Loading...
XTAI
3054
Market cap159mUSD
Jul 09, Last price  
63.40TWD
1D
3.59%
1Q
-15.69%
Jan 2017
119.20%
IPO
-71.69%
Name

LIWANLI Innovation Co Ltd

Chart & Performance

D1W1MN
XTAI:3054 chart
P/E
32.33
P/S
40.73
EPS
1.96
Div Yield, %
Shrs. gr., 5y
-0.66%
Rev. gr., 5y
-14.63%
Revenues
126m
+26.61%
1,243,110,0001,019,155,0002,317,240,0002,736,562,0002,443,691,0002,235,930,000834,909,000323,097,000348,213,000185,512,000129,782,000276,879,00047,813,00033,988,00038,887,00099,156,000125,540,000
Net income
158m
P
86,816,000117,287,00035,782,000-58,152,000289,775,00015,304,000-103,453,00062,796,00081,910,000891,0002,782,000-13,613,00045,563,000-120,907,0005,103,000-32,074,000158,146,000
CFO
-72m
L
89,430,00078,412,000-157,772,000-104,023,000-89,820,000473,038,00034,044,000112,684,00096,034,000-123,090,000-109,160,000-36,627,000-61,133,00078,479,000-50,343,00014,202,000-71,778,000
Dividend
Jun 28, 20180.3998 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

LIWANLI Innovation Co., Ltd. operates within the biomedical science sector, concentrating on the development and distribution of nutrition and healthcare solutions. The company's diverse product portfolio, which notably features the Vigoway line and various powdered formulations, is designed to serve a wide range of consumers, including men, women, seniors, and children. Its extensive offerings encompass products such as probiotic enzymes, active nutrients, resveratrol red grape extract, and a variety of soft gels (including those with algae DHA, shea butter with type II collagen, and algae astaxanthin Q10). Other specialized items include cordyceps militaris powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, and DHA and vitamin D3 drops, among others. The firm was formerly known as Carry Technology International Co., Ltd. before officially adopting its current name, LIWANLI Innovation Co., Ltd., in 2015. Established in 1980, the company's headquarters are located in New Taipei City, Taiwan.
IPO date
Jul 22, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT